Clarius Group, LLC
- SEC CIK
- 0001664214
- Latest filing
- Jan 14, 2026
DNLI holding history
Denali Therapeutics Inc. in every 13F filed by Clarius Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNLI overviewAll 13F holders of DNLIFull Q4 2025 holdings
- Shares (Q4 2025)
- 368,995
- Value
- $6.09M
- % of portfolio
- 0.3%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 368,995 | $6.09M | 0.3% | +9,250+2.6% | Added | Holders |
| Q3 2025 | 359,745 | $5.22M | 0.3% | −9,250−2.5% | Reduced | Holders |
| Q2 2025 | 368,995 | $5.16M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2025 | 368,995 | $5.02M | 0.3% | −41,000−10.0% | Reduced | Holders |
| Q4 2024 | 409,995 | $8.36M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2024 | 409,995 | $11.9M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2024 | 409,995 | $9.52M | 0.7% | +17,777+4.5% | Added | Holders |
| Q1 2024 | 392,218 | $8.05M | 0.6% | +13,956+3.7% | Added | Holders |
| Q4 2023 | 378,262 | $8.12M | 0.7% | 00.0% | Unchanged | Holders |
| Q3 2023 | 378,262 | $7.80M | 0.7% | −50.0% | Reduced | Holders |
| Q2 2023 | 378,267 | $11.2M | 0.9% | +87,937+30.3% | Added | Holders |
| Q1 2023 | 290,330 | $6.69M | 0.6% | +29,726+11.4% | Added | Holders |
| Q4 2022 | 260,604 | $7.25M | 0.7% | 00.0% | Unchanged | Holders |
| Q3 2022 | 260,604 | $8.00M | 0.8% | +232,085+813.8% | Added | Holders |
| Q2 2022 | 28,519 | $839.0K | 0.1% | +2,074+7.8% | Added | Holders |
| Q1 2022 | 26,445 | $1.18M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 26,445 | $1.18M | 0.1% | +13,750+108.3% | Added | Holders |
| Q3 2021 | 12,695 | $640.0K | 0.1% | +8,562+207.2% | Added | Holders |
| Q2 2021 | 4,133 | $324.0K | <0.1% | +4,133 | New | Holders |